InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001659075-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-03-04 2026-03-02+ ELV Penczek Ronald W CAO, Ctrl F - Tax $291.86 -168 1,743 -9% -$49.0K
DM 2026-03-04 2026-03-02 ELV Penczek Ronald W CAO, Ctrl A - Grant $0.00 +2,393 4,136 +137% $0
D 2026-03-04 2026-03-02 ELV Penczek Ronald W CAO, Ctrl A - Grant $0.00 +1,677 1,677 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-03 F D 37 $284.03 4,099 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
2 Common Common Stock 2026-03-02 F D 131 $294.07 1,743 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. (F2) Balance includes 7.06 shares acquired on March 25, 2025, 6.14 shares acquired on June 25, 2025, 7.18 shares acquired on September 25, 2025 and 6.85 shares acquired on December 19, 2025 through a dividend reinvestment plan.
3 Common Common Stock 2026-03-02 A A 426 $0.00 2,169 D — — (F3) Represents restricted share units. Restrictions lapse as follows: 142 shares on 3/2/2027, 3/2/2028 and 3/2/2029.
4 Common Common Stock 2026-03-02 A A 1,701 $0.00 3,870 D — — (F4) Represents restricted share units. Restrictions lapse as follows: 850 shares on 3/2/2027, and 851 shares on 3/2/2028.
5 Common Common Stock 2026-03-02 A A 266 $0.00 4,136 D — — (F5) Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
6 Derivative Employee Stock Option (Right to Buy) 2026-03-02 A A 1,677 $0.00 1,677 D $294.07 · — to 2036-03-02 1,677 Common Stock (F6) The option represents a right to purchase a total of 1,677 shares, and is exercisable in three annual installments, each installment of 559 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.